Al-Mosawi AJ. Post kala-azar Dermal Leishmaniasis: Sodium Stibogluconate Cardiac Toxicity. Science World Journal of Microbiology and Infectious Disease 2020;1(1):1-3. Published: 26, January 2020.Doi: 10.5281/zenodo.3878464 https://scienceworldpublishing.org/journals/science-world-journal-of-microbiology-and-infectious-disease/SWJMID https://scienceworldpublishing.org/science-world/articlepdf/swjmid-1-102%20new.pd
Use of parenteral pentavalent antimonials to treat leishmaniasis is associated with a range of cardi...
Post Kala-azar Dermal Leishmaniasis (PKDL) is a sequel of Visceral Leishmaniasis (VL). The patients ...
Objective: The aim of this study was to determine the complications of kala pathar poisoning. Mater...
Background: Kala-azar [visceral leishmaniasis (VL)] is caused by the protozoon Leishmania donovani c...
<div><p>Sodium stibogluconate solution is administered by intramuscular injection for 30 days. The i...
This descriptive cross-sectional study was carried out in the Department of Medicine, Rajshahi Medic...
Foi avaliada a toxicidade de dois antimoniais pentavalentes em 111 pacientes com leishmaniose cutâne...
Foi avaliada a toxicidade de dois antimoniais pentavalentes em 111 pacientes com leishmaniose cutâne...
Ever since their discovery about 60 years ago as therapeutic agent for visceral leishmaniasis (VL) o...
Post-kala-azar dermal leishmaniasis (PKDL) is a common dermatological complication following success...
A case of visceral leishmaniasis (Kala-azar) in a 60-year-old Nigerian female is presented. The clin...
Foi avaliada a toxicidade de dois antimoniais pentavalentes em 111 pacientes com leishmaniose cutâne...
Background and Aims: A retrospective analysis of treatment outcome using recommended dose of sodium ...
Background and Aims: A retrospective analysis of treatment outcome using recommended dose of sodium ...
Between April 9 and May 5 2000, an outbreak of fatal cardiotoxicity occurred in Nepal amongst viscer...
Use of parenteral pentavalent antimonials to treat leishmaniasis is associated with a range of cardi...
Post Kala-azar Dermal Leishmaniasis (PKDL) is a sequel of Visceral Leishmaniasis (VL). The patients ...
Objective: The aim of this study was to determine the complications of kala pathar poisoning. Mater...
Background: Kala-azar [visceral leishmaniasis (VL)] is caused by the protozoon Leishmania donovani c...
<div><p>Sodium stibogluconate solution is administered by intramuscular injection for 30 days. The i...
This descriptive cross-sectional study was carried out in the Department of Medicine, Rajshahi Medic...
Foi avaliada a toxicidade de dois antimoniais pentavalentes em 111 pacientes com leishmaniose cutâne...
Foi avaliada a toxicidade de dois antimoniais pentavalentes em 111 pacientes com leishmaniose cutâne...
Ever since their discovery about 60 years ago as therapeutic agent for visceral leishmaniasis (VL) o...
Post-kala-azar dermal leishmaniasis (PKDL) is a common dermatological complication following success...
A case of visceral leishmaniasis (Kala-azar) in a 60-year-old Nigerian female is presented. The clin...
Foi avaliada a toxicidade de dois antimoniais pentavalentes em 111 pacientes com leishmaniose cutâne...
Background and Aims: A retrospective analysis of treatment outcome using recommended dose of sodium ...
Background and Aims: A retrospective analysis of treatment outcome using recommended dose of sodium ...
Between April 9 and May 5 2000, an outbreak of fatal cardiotoxicity occurred in Nepal amongst viscer...
Use of parenteral pentavalent antimonials to treat leishmaniasis is associated with a range of cardi...
Post Kala-azar Dermal Leishmaniasis (PKDL) is a sequel of Visceral Leishmaniasis (VL). The patients ...
Objective: The aim of this study was to determine the complications of kala pathar poisoning. Mater...
DOI
Add to ORKG